Belgium · Series A startup

Who invested in Amyl Therapeutics

One round we have observed, with the 0 investors named in it. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.

Biotech

Raised 2 months ago

Funding summaryUpdated 26 Oct 2026

$9.6Mraised across 1 round since 2026, from 1 source

Latest round
Series A, $9.6MSept 2026
Investors
0
See who backed them

The rounds

  1. Sept 2026
    Series A$9.6M

    No investor was named in the report.

    Source recorded

Also claim to have backed them

This firm lists Amyl Therapeutics as a portfolio company on their own website, but no report of a round names it. They are the firms' own claims, kept apart from the rounds above.

JFG Life Sciences FoundationVC firmPer its own site

Quick answers about Amyl Therapeutics

How much has Amyl Therapeutics raised?

Amyl Therapeutics has raised $9.6M across 1 round since 2026.

When did Amyl Therapeutics last raise?

Amyl Therapeutics's most recent round was a Series A of $9.6M in Sept 2026.

What was Amyl Therapeutics's biggest round?

Its most recent round, $9.6M in Sept 2026, is also its largest on record.

What stage is Amyl Therapeutics at?

Amyl Therapeutics's latest named round is a Series A, in Sept 2026.

Where is Amyl Therapeutics based?

Amyl Therapeutics is based in Belgium.

Companies like Amyl Therapeutics

In the same sector, and raised in the last eighteen months.

Find investors like these

Search every investor by what they have actually funded, then narrow to your stage and market. Free.